TareSphere

· Chengdu New Radiomedicine Technology Co. LTD.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TareSphere, covering 2025-05-20 to 2026-06-09. Get the full timeline:

Most recent: Clinical Trial Update: Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere [Phase 3]